Diltiazem Hydrochloride Injection

• • Diltiazem Hydrochloride injection, Akorn, 5 mg/mL, 10 mL vial, 10 count, NDC 17478-0937-10
  • Diltiazem Hydrochloride injection, Akorn, 5 mg/mL, 25 mL vial, 1 count, NDC 17478-0937-25
  • Diltiazem Hydrochloride injection, Akorn, 5 mg/mL, 5 mL vial, 10 count, NDC 17478-0937-05
  • Diltiazem Hydrochloride injection, Hikma, 5 mg/mL, 10 mL vial, 10 count, NDC 00641-6014-10
  • Diltiazem Hydrochloride injection, Hikma, 5 mg/mL, 25 mL vial, 10 count, NDC 00641-6015-10
  • Diltiazem Hydrochloride injection, Hikma, 5 mg/mL, 5 mL vial, 10 count, NDC 00641-6013-10
  • Diltiazem Hydrochloride injection, Pfizer, 5 mg/mL, 10 mL vial, 10 count, NDC 00409-1171-02
  • Diltiazem Hydrochloride injection, Pfizer, 5 mg/mL, 5 mL vial, 10 count, NDC 00409-1171-01
  • Diltiazem Hydrochloride lyophilized powder for solution for injection, Pfizer, 100 mg, ADD-Vantage vial, 10 count, NDC 00409-4350-03

• • Akorn states the reason for the shortage was increased demand due to market conditions. They are not currently producing the 25 mL vials in 10 count.
  • Pfizer states the reasons for the shortage is manufacturing delays and increases in demand.
  • Hilkma has diltiazem injection on shortage due to manufacturing delays caused by increased demand due to current market conditions.

• • There is insufficient supply for usual ordering

Estimated Resupply Dates

• • Akorn has diltiazem 5 mg/mL 5 mL, 10 mL, and 25 mL vials on back order and the company cannot estimate a release date.
  • Hikma has diltiazem 5 mg/mL 5 mL vials on allocation. The 10 mL and 25 mL vials are on intermittent back order and the company is releasing supplies as they become available.
  • Pfizer has 100 mg ADD-Vantage vials on back order and the company estimates a release date of November 2018. The 5 mg/mL 5 mL and 10 mL vials are also on back order and the company estimates a release date of 2019.